Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus

A vaccine regimen that elicits broadly neutralizing antibodies (bNAbs) is a major goal in HIV-1 vaccine research. In this study, we assessed the immunogenicity of the CAP256 superinfecting viral envelope (CAP256 SU) protein delivered by modified vaccinia virus Ankara (MVA) and DNA vaccines in differ...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Virol
Main Authors: van Diepen, Michiel T., Chapman, Rosamund, Douglass, Nicola, Galant, Shireen, Moore, Penny L., Margolin, Emmanuel, Ximba, Phindile, Morris, Lynn, Rybicki, Edward P., Williamson, Anna-Lise
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2019
Teme:
Vaccines and Antiviral Agents
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6450106/
https://ncbi.nlm.nih.gov/pubmed/30760570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02155-18
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki